These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 17659597)

  • 1. Metabolic correlates of nonalcoholic fatty liver in women and men.
    Vega GL; Chandalia M; Szczepaniak LS; Grundy SM
    Hepatology; 2007 Sep; 46(3):716-22. PubMed ID: 17659597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic consequences of hepatic steatosis in overweight and obese adolescents.
    Wicklow BA; Wittmeier KD; MacIntosh AC; Sellers EA; Ryner L; Serrai H; Dean HJ; McGavock JM
    Diabetes Care; 2012 Apr; 35(4):905-10. PubMed ID: 22357180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrahepatic Fat Content and Markers of Hepatic Fibrosis in Obese Children.
    Wu W; Zhang H; Xu X; Huang K; Fu J
    Int J Endocrinol; 2016; 2016():4890974. PubMed ID: 26966436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noninvasive diagnosis of hepatic steatosis in patients with severe obesity: a clinically challenging issue.
    Cholongitas E; Chrysavgis L
    Pol Arch Intern Med; 2023 Jan; 133(1):. PubMed ID: 36692042
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of noninvasive scores to predict hepatic steatosis: Flaws and caveats.
    Adams LA; Schulte PJ; Allen AM
    Hepatology; 2023 Oct; 78(4):1029-1031. PubMed ID: 37185880
    [No Abstract]   [Full Text] [Related]  

  • 6. Editorial: New Perspectives on Hepatic Steatosis.
    Schneider CV; Alqahtani SA
    J Clin Exp Hepatol; 2024; 14(2):101359. PubMed ID: 38406388
    [No Abstract]   [Full Text] [Related]  

  • 7. Imaging evaluation in metabolic syndrome: beyond steatosis.
    Zapparoli M
    Radiol Bras; 2016; 49(1):V-VI. PubMed ID: 26929471
    [No Abstract]   [Full Text] [Related]  

  • 8. The association of dietary inflammatory index (DII) and central obesity with non-alcoholic fatty liver disease (NAFLD) in people with diabetes (T2DM).
    Soltanieh S; Salavatizadeh M; Poustchi H; Yari Z; Mansour A; Khamseh ME; Malek M; Alaei-Shahmiri F; Hekmatdoost A
    Heliyon; 2023 Mar; 9(3):e13983. PubMed ID: 36915483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CYP2E1 in Alcoholic and Non-Alcoholic Liver Injury. Roles of ROS, Reactive Intermediates and Lipid Overload.
    Harjumäki R; Pridgeon CS; Ingelman-Sundberg M
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic Concomitants of Obese and Nonobese Women With Features of Polycystic Ovarian Syndrome.
    Boumosleh JM; Grundy SM; Phan J; Neeland IJ; Chang A; Vega GL
    J Endocr Soc; 2017 Dec; 1(12):1417-1427. PubMed ID: 29264465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lean NAFLD: An Underrecognized Outlier.
    Wattacheril J; Sanyal AJ
    Curr Hepatol Rep; 2016 Jun; 15(2):134-139. PubMed ID: 27668144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of aerobic exercise on ectopic lipids in patients with growth hormone deficiency before and after growth hormone replacement therapy.
    Christ ER; Egger A; Allemann S; Buehler T; Kreis R; Boesch C
    Sci Rep; 2016 Jan; 6():19310. PubMed ID: 26792091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial steatosis as a possible mechanistic link between diastolic dysfunction and coronary microvascular dysfunction in women.
    Wei J; Nelson MD; Szczepaniak EW; Smith L; Mehta PK; Thomson LE; Berman DS; Li D; Bairey Merz CN; Szczepaniak LS
    Am J Physiol Heart Circ Physiol; 2016 Jan; 310(1):H14-9. PubMed ID: 26519031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adipose tissue and metabolic syndrome: too much, too little or neither.
    Grundy SM
    Eur J Clin Invest; 2015 Nov; 45(11):1209-17. PubMed ID: 26291691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Convergence in insulin resistance between very severely obese and lean women at the end of pregnancy.
    Forbes S; Barr SM; Reynolds RM; Semple S; Gray C; Andrew R; Denison FC; Walker BR; Norman JE
    Diabetologia; 2015 Nov; 58(11):2615-26. PubMed ID: 26248646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic Steatosis as a Marker of Metabolic Dysfunction.
    Fabbrini E; Magkos F
    Nutrients; 2015 Jun; 7(6):4995-5019. PubMed ID: 26102213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fasting, post-OGTT challenge, and nocturnal free fatty acids in prediabetic versus normal glucose tolerant overweight and obese Latino adolescents.
    Toledo-Corral CM; Alderete TL; Richey J; Sequeira P; Goran MI; Weigensberg MJ
    Acta Diabetol; 2015 Apr; 52(2):277-84. PubMed ID: 25109287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of and risk factors for non-alcoholic fatty liver disease in a non-obese Japanese population, 2011-2012.
    Nishioji K; Sumida Y; Kamaguchi M; Mochizuki N; Kobayashi M; Nishimura T; Yamaguchi K; Itoh Y
    J Gastroenterol; 2015 Jan; 50(1):95-108. PubMed ID: 24619537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic risk susceptibility in men is partially related to adiponectin/leptin ratio.
    Vega GL; Grundy SM
    J Obes; 2013; 2013():409679. PubMed ID: 23533722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. E4orf1 improves lipid and glucose metabolism in hepatocytes: a template to improve steatosis & hyperglycemia.
    Dhurandhar EJ; Krishnapuram R; Hegde V; Dubuisson O; Tao R; Dong XC; Ye J; Dhurandhar NV
    PLoS One; 2012; 7(10):e47813. PubMed ID: 23110104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.